SOUNG, J.; TIU, L.; VEVERKA, K.; HONG, C.-H. Patient Preference for Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam or Topical Suspension vs. Latest Topical Treatment in the PSO-INSIGHTFUL Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 2, n. S1, p. S10, 2018. DOI: 10.25251/skin.2.supp.10. Disponível em: https://jofskin.org/index.php/skin/article/view/279. Acesso em: 22 jul. 2024.